Nano Drug Delivery Strategies for the Treatment of Cancers discusses several current and promising approaches for the diagnosis and treatment of cancer by using the most recent developments in nanomedical technologies. The book presents introductory information about the biology of different types of cancer in order to provide the reader with knowledge on their specificities. In addition, it discusses various novel drug delivery systems, detailing their functionalities, expected outcomes and future developments in the field, focusing on brain, mouth and throat, breast, lung, liver, pancreas, stomach, colon, bool, skin and prostate cancers.
The book is a valuable source for cancer researchers, oncologists, pharmacologists and nanotechnologists who are interested in novel drug delivery systems and devices for treatment of various types of cancer that take advantage of recent advances in this exciting field.
- Discusses a wide range of promising approaches for the diagnosis and treatment of cancer using the latest advancement in cutting-edge nanomedical technologies
- Provides foundational information on different types of cancer and their biology to help the reader choose the best nano drug delivery system for patients
- Presents novel drug delivery systems based on nanoparticles, microparticles, liposomes, self-assembling Micelles and block copolymer micelles
Arvustused
"This book presents the advances made in cancer diagnosis and treatment using nano drug delivery systems. The subject matter is a complex one as it integrates cancer biology and rapidly growing nanotechnology in cancer diagnosis and treatment. There are many texts in the marketplace related to the topic, but this one is unique because it presents the use of nanomedicine in organ-based cancer diagnosis and treatment. Nevertheless, it has room for improvement. Though the authors of this book tried to be succinct, further discussions on relevant topics would be appropriate." --Doody
1. Introduction: An Overview of the Anatomy and Physiology of Different Cancers2. New
Chapter: Novel Treatment Approaches and Conventional Therapies for Effective Treatment to Cancers3. Nanoparticles and Brain Cancers4. Nanoparticles and Mouth and Throat Cancer5. Nanoparticles and Breast Cancer6. Nanoparticles and Lung Cancer7. Nanoparticles and Liver Cancer8. Nanoparticles and Pancreas Cancer9. Nanoparticles and Stomach Cancer10. Nanoparticles and Colon Cancer11. Nanoparticles and Blood Cancer12. Nanoparticles and Skin Cancer13. Nanoparticles and Prostate Cancer
Dr. Awesh K. Yadav has received his B.Pharm, M.Pharm, and PhD from Dr. Hari Singh Gour University Sagar (MP). He is currently working as Assistant Professor in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research Raebareli, India. He has more than 15 years of teaching and industrial experience in various institutes and industries. He has written dozens of quality research publications in journals of national and international repute. He has also published four books and seven book chapters. He has been awarded the best citation award for his publication in the International Journal of Pharmaceutics in 2005. Dr. Yadavs current research interest includes targeted and controlled novel drug delivery systems for the delivery of various bioactives such as anticancer drugs, anti-Alzheimer's drugs, anti-Parkinson drugs, anti-malarial drugs, sun-screening agents, etc.
Currently working as Assistant Professor at Department of Pharmacy, Central University of Rajasthan, India, received his Ph.D. in Pharmaceutical Sciences from Dr. H. S. Gour University, India under the mentorship of Prof. N K Jain. He has experience as Research Scientist at Ranbaxy Research Laboratories, India and Post-Doctoral Research Associate at South Dakota State University, USA. He has more than ten years of research and academic experience. His area of research is mainly focused on dendrimer mediated drug delivery, solubilization and targeting. He has more than 49 publications and six book chapters to his credit with total citations of more than 2855. Recently he has also published a book with Elsevier as Editor entitled Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors”. Rajeev Sharma is an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Madhya Pradesh, Gwalior, India. He earned his B.Pharm, M.Pharm, and Ph.D. in Pharmaceutical Sciences from Dr. H. S. Gour Central University, Sagar, India. Dr. Sharma has approximately 13 years of experience in both teaching and industry. He has served as a Junior Research Fellow under AICTE, an ICMR-SRF, and a CSIR-RA Fellow during his research career, and has worked as an Assistant Professor in academia and as a Senior Formulation Development Scientist in the R&D industry. Dr. Sharma has edited two international and two national books and has authored over 30 publications and 21 book chapters in international reference books. His work focuses on recent concepts in immunology, nanobiotechnology, novel drug delivery systems, and targeted and controlled drug delivery of bioactives for the treatment of diseases such as cancer and diabetes. He is a life member of the Association of Pharmaceutical Teachers of India (APTI). Dr. Sharma's work has been cited approximately 1,200 times, and he has an h-index of 17. The cumulative impact factor of his published papers is around 120, according to SCOPUS. He is currently working on a research project funded by the Madhya Pradesh Council of Science and Technology (MPCST). Dr. Sharma has received several awards for his research, including the Young Research Scholar award and various awards for best oral and poster presentations at national and international conferences. His current research interest is in nanocarrier-based targeted approaches for the effective delivery of bioactives.
Lisainfo e-raamatute kohta